Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
Figure 2
(a) Animal weights recorded at days 20, 23, 27, 30, and 34 after SaOS-2 intratibial injection. There was no significant weight loss compared to control. (b) Biochemical analysis of serum collected postmortem (±SEM). There was no evidence of renal or hepatic toxicity.
